Related Experiment Videos
Kaposi's disease and sarcoidosis
L Corda1, D Benerecetti, M Ungari
1Terza Divisione di Medicina Generale, Spedali Civili, Brescia, Italy.
The European Respiratory Journal
|February 1, 1996
Summary
A 65-year-old woman developed Kaposi's disease and sarcoidosis after long-term corticosteroid treatment for uveitis. This case highlights potential links between immune dysregulation, corticosteroid therapy, and disease development.
Area of Science:
- Immunology
- Dermatology
- Ophthalmology
Background:
- A 65-year-old human immunodeficiency virus (HIV) antibody-negative woman presented with bilateral uveitis.
- The patient underwent 7 years of corticosteroid treatment for the uveitis.
Observation:
- Erythematous skin lesions appeared on the patient's legs one year into corticosteroid therapy.
- Gastric and bronchial biopsies revealed noncaseating epithelioid cell granulomas.
- A cutaneous biopsy confirmed Kaposi's disease.
Findings:
- The patient was diagnosed with sarcoidosis and Kaposi's disease.
- The development of these conditions occurred following prolonged corticosteroid use for uveitis.
Implications:
- This case suggests that sarcoidosis-associated immune dysregulation, potentially exacerbated by corticosteroid therapy, may promote the development of Kaposi's disease.
- Further research is warranted to understand the intricate relationship between immunosuppression, autoimmune conditions, and the manifestation of opportunistic or secondary diseases.